Search results
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
Motley Fool via Yahoo Finance· 2 months agoSome investors might remember the obesity drugs developed by Arena Pharmaceuticals and Vivus...
2 Incredible Growth Stocks That Are Screaming Buys for 2024
Motley Fool via Yahoo Finance· 4 months agoThe new year is here, and for many, it's a fresh opportunity to set financial goals and find fresh...
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma...
Motley Fool via Yahoo Finance· 2 months agoIt's hard to overstate just how successful the expansions of new diabetes treatments into the weight...
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
Motley Fool· 9 months agoRegeneron Pharmaceuticals (NASDAQ: REGN) is a leader in the field of therapeutic proteins, with a...
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
Motley Fool· 6 months agoPfizer's (NYSE: PFE) stock performance has been disappointing this year (down 38%). For example,...
Is Eli Lilly's Latest Deal a Gamechanger?
Motley Fool via Yahoo Finance· 2 weeks agoOne of the biggest contributors to growth in the pharmaceutical industry right now is weight-loss medicine. Diabetes and obesity treatments from Novo...
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
Investor's Business Daily· 5 months agoPharma and biotech stocks, led by Eli Lilly, Biogen and Crispr, are setting up for significant gains...
3 No-Brainer Stocks You Can Buy Right Now
Motley Fool· 11 months agoHere's why they think AbbVie (NYSE: ABBV), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer stocks to buy right now. Prosper...
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Robust Resilience
GuruFocus.com via Yahoo Finance· 8 months agoIn the ever-evolving world of the stock market, uncovering potential gold mines is paramount for...
Why Pfizer Likely Isn't Done With M&A After the Seagen Deal
Motley Fool· 1 year agoPfizer (NYSE: PFE) has been a company on a mission, looking to restock its pipeline with growth...